Communiqués DENI CAPPAR

Actions

DNQAF

KYG6256B1068

Marché Fermé - OTC Markets 21:58:52 08/10/2026			Varia. 5j.	Varia. 1 janv.
0,4200 ^USD	0,00%		-26,32%	-96,51%

22/09/25	Semnur Pharmaceuticals finalise l'acquisition de Denali Capital Acquisition Corp. via une fusion inversée	CI
21/08/25	Denali Capital Acquisition Corp. et Semnur Pharmaceuticals, Inc. concluent un accord d'achat : les fonds serviront à financer la seconde phase 3 de l'essai clinique sur le SP-102	CI

Communiqués

13/08/25	Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex	AQ
12/06/25	Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination	GL
09/05/25	Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination	GL
14/04/25	Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination	GL
14/04/25	Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination	AQ
10/04/25	Denali Capital Acquisition Corp. Announces Adjournment of Extraordinary General Meeting of Shareholders to April 11, 2025 at 10:00 AM ET.	AQ
10/04/25	Denali Capital Acquisition Corp. Announces Adjournment of Extraordinary General Meeting of Shareholders to April 11, 2025 at 10:00 AM ET.	GL
11/03/25	Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination	GL
11/02/25	Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination	GL
08/01/25	Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination	GL
11/12/24	Denali Capital Acquisition : Announces Extension of Deadline to Complete Business Combination Form 8 K	PU
11/12/24	Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination	GL
12/11/24	Denali Capital Acquisition : Announces Extension of Deadline to Complete Business Combination Form 8 K	PU
11/11/24	Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination	GL
11/10/24	Denali Capital Acquisition : Announces Extension of Deadline to Complete Business Combination Form 8 K	PU
11/10/24	Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination	GL
11/09/24	Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination	GL
03/09/24	Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination	GL
09/08/24	Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination	AQ
09/08/24	Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination	GL
17/07/24	Denali Capital Acquisition : Change in Certifying Accountants Form 8 K	PU
10/07/24	Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination	GL
27/06/24	Correction: Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination	GL
11/06/24	Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination	GL
10/05/24	Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination	GL